Full Press Release Details
Canopy Growth to join the S&P/TSX
SMITHS FALLS, ON, April 12, 2019 /CNW/ - Canopy
Growth Corporation (TSX: WEED) (NYSE: CGC) ("Canopy Growth" or "the Company") today announced that the Company
is to join the S&P/TSX 60 Index, achieving another public market "first" for the cannabis industry.
Canopy Growth to join the S&P/TSX 60 Index
(CNW Group/Canopy Growth Corporation)
"Being added to the S&P/TSX 60 Index
marks another major accomplishment for our company, team, and shareholders," said Bruce Linton, Founder, Chairman & Co-CEO.
"First traded on the TSX Venture Exchange on April 4, 2014, I cannot think of a better way to celebrate our 5th
year anniversary as a publicly traded company, than being added to the TSX's large-cap index."
The addition of the Company to the S&P/TSX
60 Index will be effective prior to the commencement of trading on April 18, 2019.
To be eligible for inclusion on the S&P/TSX
60 Index, securities must meet certain market capitalization, liquidity and domicile requirements. For more information on
the S&P/TSX Composite Index, please visit https://ca.spindices.com/indices/equity/sp-tsx-60-index.
About Canopy Growth Corporation
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties
in dried, oil and Softgel capsule forms. Canopy Growth offers medically approved vaporizers through the Company's subsidiary, Storz
& Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for
leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The Company has
operations in over a dozen countries across five continents.
The Company is proudly dedicated to educating
healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and through
its wholly owned subsidiary, Canopy Health Innovations ("Canopy Health"), has devoted millions of dollars toward cutting
edge, commercializable research and IP development. Canopy Growth works with the Beckley Foundation and has launched Beckley Canopy
Therapeutics to research and develop clinically validated cannabis-based medicines, with a strong focus on intellectual property
protection. Canopy Growth acquired assets of leading hemp research company, ebbu, Inc. ("ebbu"). Intellectual Property
("IP") and R&D advancements achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis
genetic breeding program and its cannabis-infused beverage capabilities. Through partly owned subsidiary Canopy Rivers Corporation,
the Company is providing resources and investment to new market entrants and building a portfolio of stable investments in the
From our historic public listing on the Toronto
Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through
leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including
cannabis icon Snoop Dogg, breeding legends DNA Genetics and Green House seeds, Battelle, the world's largest nonprofit research
and development organization, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates ten
licensed cannabis production sites with over 4.4 million square feet of production capacity, including over 500,000 square feet
of GMP certified production space. For more information visit www.canopygrowth.com
Notice Regarding Forward Looking Statements
This news release contains "forward-looking statements" within the meaning of the United States Private Securities Litigation
Reform Act of 1995 and "forward-looking information" within the meaning of applicable Canadian securities legislation.
Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans",
"expects" or "does not expect", "is expected", "estimates", "intends", "anticipates"
or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions,
events or results "may", "could", "would", "might" or "will" be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from
any future results, performance or achievements expressed or implied by the forward-looking statements or information contained
in this news release. Examples of such statements include statements with respect to inclusion in public market indexes. Risks,
uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects
and opportunities to differ materially from those expressed or implied by such forward-looking information, including the Company's
ability to satisfy provincial sales contracts or provinces purchasing all cannabis allocated to them, and such risks contained
in the Company's annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company's
issuer profile on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the
forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed
on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking
information and forward-looking statements included in this news release are made as of the date of this news release and the Company
does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect
new information, subsequent events or otherwise unless required by applicable securities laws.
View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-to-join-the-sptsx-60-index-300831343.html
SOURCE Canopy Growth Corporation
View original content to download multimedia:
For further information: Caitlin O'Hara, Media Relations,
Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations, Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext.
CO: Canopy Growth Corporation
CNW 09:04e 12-APR-19